Skip to content

Effects of combination of the application of Electric Current and Massage on bruxism

Effects of Electromassage in adults with bruxism: a randomized clinical trial controlled

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-688c6mb
Enrollment
Unknown
Registered
2022-11-24
Start date
2022-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bruxism

Interventions

This is a two-arm, single-blind, randomized controlled clinical trial. Participation of the experimental group 30 adults with bruxism will undergo the application of electromassage, with glove electro
E02.331
E02.190.599.750.750
E02.779

Sponsors

Universidade Federal do Paraná
Lead Sponsor
Universidade Federal do Paraná
Collaborator

Eligibility

Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Volunteers of both sexes; between 18 and 40 years of age; with a diagnosis of problable bruxism that will be based in the presence of a positive result in the self-report and clinical odontological inspetion

Exclusion criteria

Exclusion criteria: Participants under the age of 18; who do not agree to participate in this study or who have cognitive deficit determined by the MMSE questionnaire - Mini Mental State Examination; hearing deficit that prevents understanding of verbal instructions; neuromuscular disorders and/or trauma-orthopedic conditions that prevent the participant from carrying out the assessments and/or proposed intervention; pregnant or lactating women; individuals diagnosed with cancer and autoimmune diseases; present other associated osteoarticular disorders at the application site; have severe symptoms of depressive disorders and/or anxiety disorders, alcohol and/or drug abuse; daily use of pain control medication (as preventive medication for the treatment of chronic tension headache and/or migraine); present tooth loss of more than two posterior teeth, except third molars; who are on concomitant treatment for bruxism; users of occlusal splints, complete dentures, removable partial dentures and orthodontic appliances; who have not taken at least the first dose of the Covid-19 vaccine

Design outcomes

Primary

MeasureTime frame
Self-reported bruxism score on a 5-point Likert scale (never, rarely, sometimes, frequently and continuously) and evaluation of pain using Visual Analog Scale (EVA) and algometry (portion of the sternal portion of the sternocleidomastoid muscle and the superficial muscle fibers of the trapezius muscle) evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.

Secondary

MeasureTime frame
Assessment of mandibular functionality limitation using the Mandibular Functional Limitation Questionnaire and Index (MIFQ) and the Jaw Functional Limitation Scale (JFLS-20). It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of mandibular opening evaluated by the maximum mouth opening measured by digital caliper, being considered limited to opening with a value of less than 40 mm. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of harmful oral behaviors during sleep and wakefulness using the Oral Behavior Checklist (OBC). It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of sleep quality using the Pittsburgh Sleep Quality Index (PSQI). It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of the perception of stress through the Stress Perception Scale. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of anxiety by the Generalized Anxiety Disorders and Anxiety Questionnaire (GAD-7) and of depression by the Depression Symptoms Severity Questionnaire (Patient Health Questionnaire PHQ-9. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Satisfaction with electromassage through a resource satisfaction questionnaire on a 5-point Likert scale. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.

Countries

Brazil

Contacts

Public ContactRaciele Korelo

Universidade Federal do Paraná

raciele@ufpr.br+55 (41) 3360-4330

Outcome results

None listed

Source: REBEC (via WHO ICTRP)